Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe Record History page now includes an added revision entry for Revision: v3.3.2 and the entry Revision: v3.2.0 is removed.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding and operating status notice on the Record History page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedThe history shows updates to the Study Status and Recruitment Status across revisions. Later versions add details on Study Design and Contacts/Locations.SummaryDifference0.1%

- Check82 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference13%

- Check89 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.